|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000146828 |
Summary for SLC12A9 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000146828 | Gene symbol | SLC12A9 |
| Gene name | solute carrier family 12 member 9 | |
| HGNC | 17435 | |
| Entrez ID | 56996 | |
| Gene type | protein_coding | |
| Synonyms | SLC12A9|CIP1 | |
| UniProtAcc | Q9BXP2 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for SLC12A9 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| SLC12A9 | 4.19e+03 | 1.09e+00 | 2.54e-01 | 4.28e+00 | 1.83e-05 | 2.50e-04 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| SLC12A9 | 2.92e+03 | 1.39e+00 | 2.73e-01 | 5.09e+00 | 3.61e-07 | 3.62e-06 | READ |
Top |
Sex-biased somatic mutation for SLC12A9 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for SLC12A9 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| SARC | cg10350880 | chr7:100825598 | CGI:chr7:100826802-100828004 | promoter | 5.20e-01 | 6.26e-01 | -2.49e+00 | 1.26e-02 | 2.15e-02 | -1.06e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg22083684 | chr7:100828205 | CGI:chr7:100826802-100828004 | promoter,gene body | 2.10e-01 | 6.24e-02 | 8.01e+00 | 1.14e-15 | 4.39e-15 | 1.48e-01 |
| LUAD | cg10350880 | chr7:100825598 | CGI:chr7:100826802-100828004 | promoter | 5.10e-01 | 3.60e-01 | 2.23e+00 | 2.58e-02 | 3.10e-02 | 1.50e-01 |
Top |
Exon skipping events with PSI in TCGA for SLC12A9 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for SLC12A9 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | SLC12A9-201 | chr7_100856686_+ | 1.90e-01 | 1.50e-01 | 2.38e+00 | 1.74e-02 | 3.59e-02 | 3.95e-02 |
| THCA | SLC12A9-201 | chr7_100856732_+ | 3.96e-01 | 2.70e-01 | 2.15e+00 | 3.18e-02 | 4.91e-02 | 1.26e-01 |
| LUSC | SLC12A9-201 | chr7_100855356_+ | 2.92e-01 | 4.46e-01 | -2.62e+00 | 8.68e-03 | 4.91e-02 | -1.54e-01 |
| BLCA | SLC12A9-201 | chr7_100856712_+ | 1.75e-01 | 2.31e-01 | -2.19e+00 | 2.83e-02 | 4.98e-02 | -5.65e-02 |
| STAD | SLC12A9-201 | chr7_100855357_+ | 6.02e-01 | 4.50e-01 | 2.54e+00 | 1.11e-02 | 4.96e-02 | 1.52e-01 |
| STAD | SLC12A9-201 | chr7_100856679_+ | 1.62e-01 | 2.25e-01 | -2.19e+00 | 2.88e-02 | 4.96e-02 | -6.26e-02 |
| STAD | SLC12A9-201 | chr7_100856732_+ | 3.38e-01 | 3.87e-01 | -2.43e+00 | 1.51e-02 | 4.96e-02 | -4.85e-02 |
| GBM | SLC12A9-201 | chr7_100856726_+ | 2.95e-01 | 3.54e-01 | -2.23e+00 | 2.57e-02 | 4.96e-02 | -5.88e-02 |
| ESCA | SLC12A9-201 | chr7_100855356_+ | 3.98e-01 | 5.54e-01 | -2.04e+00 | 4.10e-02 | 4.99e-02 | -1.56e-01 |
| ESCA | SLC12A9-201 | chr7_100855390_+ | 4.51e-01 | 6.32e-01 | -2.58e+00 | 9.79e-03 | 4.99e-02 | -1.81e-01 |
| ESCA | SLC12A9-201 | chr7_100857814_+ | 2.76e-01 | 1.72e-01 | 2.08e+00 | 3.75e-02 | 4.99e-02 | 1.04e-01 |
| LAML | SLC12A9-201 | chr7_100855190_+ | 4.14e-01 | 2.98e-01 | 2.04e+00 | 4.09e-02 | 4.95e-02 | 1.16e-01 |
| THYM | SLC12A9-201 | chr7_100856732_+ | 3.96e-01 | 3.00e-01 | 2.10e+00 | 3.54e-02 | 4.81e-02 | 9.62e-02 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| BRCA | SLC12A9-201 | chr7_100856712_+ | 2.30e-01 | 3.19e-01 | -2.03e+00 | 4.27e-02 | 4.44e-02 | -8.83e-02 |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for SLC12A9 |
| TFs related to SLC12A9. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | NHLH1 | SLC12A9 | 3.06e+00 | 4.31e-03 | 4.54e+00 | 9.86e-01 | Female-biased |
| BRCA | NR1H4 | SLC12A9 | 2.99e+00 | 4.69e-03 | 4.44e+00 | 9.84e-01 | Female-biased |
| BRCA | SNAI1 | SLC12A9 | 3.14e+00 | 5.27e-03 | 4.56e+00 | 9.86e-01 | Female-biased |
| BRCA | TCF12 | SLC12A9 | 3.03e+00 | 6.25e-03 | 4.39e+00 | 9.81e-01 | Female-biased |
| BRCA | TCF3 | SLC12A9 | 3.14e+00 | 3.97e-03 | 4.65e+00 | 9.88e-01 | Female-biased |
| BRCA | TFAP2A | SLC12A9 | 3.28e+00 | 9.15e-03 | 4.52e+00 | 9.81e-01 | Female-biased |
| BRCA | TFAP2B | SLC12A9 | 3.28e+00 | 8.33e-03 | 4.55e+00 | 9.83e-01 | Female-biased |
| BRCA | TFAP2C | SLC12A9 | 3.35e+00 | 9.26e-03 | 4.59e+00 | 9.82e-01 | Female-biased |
| BRCA | ZFX | SLC12A9 | 3.17e+00 | 5.37e-03 | 4.58e+00 | 9.86e-01 | Female-biased |
| BRCA | ZIC2 | SLC12A9 | 3.00e+00 | 4.92e-03 | 4.43e+00 | 9.84e-01 | Female-biased |
| BRCA | ZNF101 | SLC12A9 | 3.26e+00 | 5.42e-03 | 4.67e+00 | 9.87e-01 | Female-biased |
| BRCA | ZNF141 | SLC12A9 | 3.18e+00 | 4.92e-03 | 4.62e+00 | 9.87e-01 | Female-biased |
| BRCA | ZNF264 | SLC12A9 | 3.35e+00 | 9.21e-03 | 4.59e+00 | 9.82e-01 | Female-biased |
| BRCA | ZNF28 | SLC12A9 | 3.22e+00 | 5.58e-03 | 4.61e+00 | 9.86e-01 | Female-biased |
| BRCA | ZNF320 | SLC12A9 | 2.83e+00 | 4.42e-03 | 4.29e+00 | 9.81e-01 | Female-biased |
| BRCA | ZNF322 | SLC12A9 | 2.91e+00 | 5.37e-03 | 4.31e+00 | 9.81e-01 | Female-biased |
| BRCA | ZNF331 | SLC12A9 | 3.12e+00 | 5.40e-03 | 4.53e+00 | 9.85e-01 | Female-biased |
| BRCA | ZNF333 | SLC12A9 | 3.16e+00 | 6.27e-03 | 4.52e+00 | 9.84e-01 | Female-biased |
| BRCA | ZNF415 | SLC12A9 | 3.07e+00 | 6.36e-03 | 4.42e+00 | 9.82e-01 | Female-biased |
| BRCA | ZNF436 | SLC12A9 | 2.95e+00 | 5.85e-03 | 4.33e+00 | 9.80e-01 | Female-biased |
| BRCA | ZNF454 | SLC12A9 | 2.95e+00 | 3.42e-03 | 4.50e+00 | 9.87e-01 | Female-biased |
| BRCA | ZNF707 | SLC12A9 | 3.19e+00 | 7.22e-03 | 4.51e+00 | 9.83e-01 | Female-biased |
| BRCA | ZNF891 | SLC12A9 | 3.14e+00 | 7.01e-03 | 4.46e+00 | 9.82e-01 | Female-biased |
| SLC12A9 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for SLC12A9 |
| RBPs related to ES in SLC12A9. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | SAMD4A | exon_skip_469364 | 7.17e+00 | 9.86e-01 | 6.30e+00 | 7.82e-04 | Male-biased |
| LUAD | SAMD4A | exon_skip_469364 | 6.64e+00 | 4.91e-03 | 7.04e+00 | 9.81e-01 | Female-biased |
| KIRP | FMR1 | exon_skip_469363 | 6.89e+00 | 9.83e-01 | 6.40e+00 | 1.84e-03 | Male-biased |
| BRCA | FMR1 | exon_skip_469363 | 6.62e+00 | 6.61e-03 | 7.37e+00 | 9.82e-01 | Female-biased |
| BRCA | SAMD4A | exon_skip_469364 | 6.67e+00 | 4.35e-03 | 7.55e+00 | 9.85e-01 | Female-biased |
| THCA | SAMD4A | exon_skip_469364 | 6.79e+00 | 9.82e-01 | 6.41e+00 | 2.97e-03 | Male-biased |
| KIRC | SAMD4A | exon_skip_469364 | 6.80e+00 | 9.84e-01 | 6.30e+00 | 9.95e-04 | Male-biased |
| HNSC | FMR1 | exon_skip_469363 | 7.17e+00 | 9.84e-01 | 6.71e+00 | 3.21e-03 | Male-biased |
| SLC12A9 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs373614921 | chr7:91511870:T:C | - | 0.191010652464781 | 0.0421962355080456 | KIRP | Female-baised eQTL |
| rs34730810 | chr7:94981589:A:C | - | 0.123178476688189 | 0.00113383972101962 | LUAD | Female-baised eQTL |
| rs73714409 | chr7:103489409:T:C | - | 0.0914443603096411 | 0.00214820794069377 | LUAD | Female-baised eQTL |
| rs34575523 | chr7:94961747:T:C | - | 0.102019706114639 | 0.00241458161274323 | LUAD | Female-baised eQTL |
| rs12538626 | chr7:94979555:T:C | - | 0.102019706114639 | 0.00241458161274323 | LUAD | Female-baised eQTL |
| rs2188476 | chr7:94985661:T:C | - | 0.102019706114639 | 0.00241458161274323 | LUAD | Female-baised eQTL |
| rs13245537 | chr7:94986427:A:G | - | 0.102019706114639 | 0.00241458161274323 | LUAD | Female-baised eQTL |
| rs12666453 | chr7:94992801:C:T | - | 0.101887694014643 | 0.00247897394058346 | LUAD | Female-baised eQTL |
| rs12537155 | chr7:94994135:A:T | - | 0.101607281149892 | 0.00261055786515246 | LUAD | Female-baised eQTL |
| rs7800819 | chr7:94996029:T:C | - | 0.101607281149892 | 0.00261055786515246 | LUAD | Female-baised eQTL |
| rs35266590 | chr7:94997394:A:C | - | 0.101607281149892 | 0.00261055786515246 | LUAD | Female-baised eQTL |
| rs34367712 | chr7:94952380:T:C | - | 0.115345614866475 | 0.00277197950459436 | LUAD | Female-baised eQTL |
| rs1527678 | chr7:94956651:T:G | - | 0.115345614866475 | 0.00277197950459436 | LUAD | Female-baised eQTL |
| rs12704773 | chr7:94956933:A:C | - | 0.115345614866475 | 0.00277197950459436 | LUAD | Female-baised eQTL |
| rs1527681 | chr7:95000171:A:G | - | 0.114923855489157 | 0.00297053682346398 | LUAD | Female-baised eQTL |
| rs57556908 | chr7:106334680:A:G | - | 0.0673931940789979 | 0.00365382649918544 | LUAD | Female-baised eQTL |
| rs2299334 | chr7:103526919:G:A | - | 0.0895686873634104 | 0.00373362051961117 | LUAD | Female-baised eQTL |
| rs6466101 | chr7:106316458:T:A | - | 0.0691778765696288 | 0.004098308966272 | LUAD | Female-baised eQTL |
| rs6950522 | chr7:106323715:A:T | - | 0.0691778765696288 | 0.004098308966272 | LUAD | Female-baised eQTL |
| rs60487347 | chr7:106326353:G:T | - | 0.0691778765696288 | 0.004098308966272 | LUAD | Female-baised eQTL |
| rs10499961 | chr7:106328743:A:G | - | 0.0691778765696288 | 0.004098308966272 | LUAD | Female-baised eQTL |
| rs10499912 | chr7:94959869:A:G | - | 0.0964015437274405 | 0.00412528262643414 | LUAD | Female-baised eQTL |
| rs12666786 | chr7:94951464:A:G | - | 0.100193936153422 | 0.00417001244880379 | LUAD | Female-baised eQTL |
| rs12669284 | chr7:94969037:T:A | - | 0.100193936153422 | 0.00417001244880379 | LUAD | Female-baised eQTL |
| rs13242203 | chr7:94972556:C:T | - | 0.100193936153422 | 0.00417001244880379 | LUAD | Female-baised eQTL |
| rs7788938 | chr7:94976065:T:A | - | 0.100193936153422 | 0.00417001244880379 | LUAD | Female-baised eQTL |
| rs12539776 | chr7:94976433:T:G | - | 0.100193936153422 | 0.00417001244880379 | LUAD | Female-baised eQTL |
| rs12534484 | chr7:94977824:G:A | - | 0.100193936153422 | 0.00417001244880379 | LUAD | Female-baised eQTL |
| rs7794416 | chr7:94956331:C:T | - | 0.0998013070065061 | 0.00446041473294356 | LUAD | Female-baised eQTL |
| rs12533201 | chr7:106330887:T:C | - | 0.0687694663510261 | 0.00454438855511601 | LUAD | Female-baised eQTL |
| rs2237623 | chr7:103530228:T:C | - | 0.0683231183632438 | 0.0096009968662042 | LUAD | Female-baised eQTL |
| rs3808032 | chr7:103513373:G:C | - | 0.0838820344606531 | 0.0101261862034701 | LUAD | Female-baised eQTL |
| rs71562878 | chr7:95009204:A:G | - | 0.090580601443773 | 0.0106543716715021 | LUAD | Female-baised eQTL |
| rs12534579 | chr7:106317602:C:T | - | 0.0666645223053791 | 0.0106750929762588 | LUAD | Female-baised eQTL |
| rs28716995 | chr7:103524460:C:T | - | 0.0771455710306912 | 0.0118911321072262 | LUAD | Female-baised eQTL |
| rs12670831 | chr7:95006847:T:C | - | 0.0999928016065045 | 0.0143157642330057 | LUAD | Female-baised eQTL |
| rs10953134 | chr7:95008093:A:G | - | 0.0999928016065045 | 0.0143157642330057 | LUAD | Female-baised eQTL |
| rs12669893 | chr7:95009260:C:T | - | 0.0999928016065045 | 0.0143157642330057 | LUAD | Female-baised eQTL |
| rs35615115 | chr7:95016841:C:T | - | 0.0999928016065045 | 0.0143157642330057 | LUAD | Female-baised eQTL |
| rs144650545 | chr7:95021251:G:T | - | 0.0999928016065045 | 0.0143157642330057 | LUAD | Female-baised eQTL |
| rs12674154 | chr7:95003680:A:G | - | 0.0885639949792238 | 0.0168054903521883 | LUAD | Female-baised eQTL |
| rs7795316 | chr7:95003764:G:A | - | 0.0885639949792238 | 0.0168054903521883 | LUAD | Female-baised eQTL |
| rs12536174 | chr7:95005085:G:A | - | 0.0885639949792238 | 0.0168054903521883 | LUAD | Female-baised eQTL |
| rs35025230 | chr7:95006281:A:G | - | 0.0885639949792238 | 0.0168054903521883 | LUAD | Female-baised eQTL |
| rs12537182 | chr7:95017007:C:T | - | 0.0885639949792238 | 0.0168054903521883 | LUAD | Female-baised eQTL |
| rs35614722 | chr7:95018247:C:A | - | 0.0885639949792238 | 0.0168054903521883 | LUAD | Female-baised eQTL |
| rs12539414 | chr7:94950729:T:A | - | 0.0848503784468056 | 0.0238425109820667 | LUAD | Female-baised eQTL |
| rs2410852 | chr7:101493806:G:A | - | 0.0382098627615716 | 0.0472981893280601 | LUAD | Female-baised eQTL |
| rs12538723 | chr7:104239476:C:T | - | 0.117506049153026 | 0.00199976577791593 | COAD | Female-baised eQTL |
| rs12536622 | chr7:104079028:T:C | - | 0.0891182380725767 | 0.015257963250635 | COAD | Female-baised eQTL |
| rs4729956 | chr7:104080389:A:G | - | 0.0959235688350132 | 0.020904817035063 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs28489040 | chr7:96897538:T:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs2015735 | chr7:96897592:T:C | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10279012 | chr7:96897679:A:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10268220 | chr7:96897810:T:C | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10252964 | chr7:96897889:G:C | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs6965142 | chr7:96898592:C:T | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10256997 | chr7:96899037:C:A | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10257118 | chr7:96899077:C:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10257144 | chr7:96899149:C:A | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs352672 | chr7:96899205:A:C | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs10272991 | chr7:96899263:T:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs3823754 | chr7:96899510:A:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs1403178 | chr7:96900654:A:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs1823421 | chr7:96902592:A:G | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs1823422 | chr7:96902608:T:C | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs1823423 | chr7:96902763:T:C | - | 0.112794037161271 | 0.039055495617829 | PAAD | Male-baised eQTL |
| rs1522534 | chr7:96905697:T:G | - | 0.118046649801943 | 0.0486032223116374 | PAAD | Male-baised eQTL |
| rs1879851 | chr7:96906822:A:T | - | 0.118046649801943 | 0.0486032223116374 | PAAD | Male-baised eQTL |
| rs12704901 | chr7:96907779:T:C | - | 0.118046649801943 | 0.0486032223116374 | PAAD | Male-baised eQTL |
| rs7810058 | chr7:96912913:A:G | - | 0.118046649801943 | 0.0486032223116374 | PAAD | Male-baised eQTL |
| rs4729319 | chr7:96918101:A:G | - | 0.118046649801943 | 0.0486032223116374 | PAAD | Male-baised eQTL |
| rs11979435 | chr7:107058237:G:T | - | 0.0964027269138586 | 0.0293443501842914 | KIRC | Male-baised eQTL |
| rs58085052 | chr7:107048135:T:C | - | 0.0958262526230191 | 0.0359067653596264 | KIRC | Male-baised eQTL |
| rs17156109 | chr7:108713803:G:A | - | 0.0753474677765434 | 0.013415125538102 | BLCA | Male-baised eQTL |
| rs696265 | chr7:91086726:A:G | - | 0.0441133561808899 | 0.016262386602566 | BLCA | Male-baised eQTL |
| rs705350 | chr7:91088971:C:T | - | 0.0426184939030748 | 0.0230633624463001 | BLCA | Male-baised eQTL |
| rs696029 | chr7:91104105:A:G | - | 0.0423771541013625 | 0.027381568204355 | BLCA | Male-baised eQTL |
| rs696269 | chr7:91098437:T:G | - | 0.0408099529388384 | 0.0489933865169507 | BLCA | Male-baised eQTL |
| rs12537028 | chr7:95969963:T:G | - | 0.0681325358149463 | 0.030384528686195 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000146828 |
| CpG Site: cg21406967 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.054858213208442 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg21406967 | chr7:100866931 | gene,exon,UTR | -0.054858213208442 | 6.34012320493723e-07 | -0.39075981993006403 | 5.579211317083377e-12 | LGG |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs3808355 | chr7:100894677:C:T | Distant downstream | -0.0282994644072918 | 0.0148545062537965 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs3808356 | chr7:100894701:C:T | Distant downstream | -0.0282994644072918 | 0.0148545062537965 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs3847067 | chr7:100902995:C:A | Distant downstream | -0.0282994644072918 | 0.0148545062537965 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs74818172 | chr7:100914916:T:C | Distant downstream | -0.028120068728003 | 0.0197601687998396 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs10274976 | chr7:99984238:C:T | Distant upstream | 0.0393241550752325 | 0.0254552587793901 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs62482549 | chr7:100919567:C:T | Distant downstream | -0.0290569547697509 | 0.0293541566907002 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs6960162 | chr7:101566836:A:G | Distant downstream | -0.027258251454964 | 0.0300690464365434 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs12538287 | chr7:100873499:C:A | Distant downstream | -0.0260664408966108 | 0.0407650259528489 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs7789085 | chr7:100875204:C:T | Distant downstream | -0.0258947962622913 | 0.0440121195673494 | THCA | Female-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs7800241 | chr7:100870481:G:A | Distant downstream | -0.0255494270227076 | 0.0497965536476839 | THCA | Female-baised sQTL |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs221795 | chr7:100685638:C:T | Distant upstream | 0.0324163407781625 | 0.00964033301119301 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs568733 | chr7:100714039:G:T | Distant upstream | 0.0274893442627706 | 0.0387513793960557 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs1734908 | chr7:100716145:G:T | Distant upstream | 0.0274893442627706 | 0.0387513793960557 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs554055 | chr7:100717633:G:C | Distant upstream | 0.0274893442627706 | 0.0387513793960557 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs576236 | chr7:100719352:C:T | Distant upstream | 0.0272066930013826 | 0.0421460612673169 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs1617640 | chr7:100719675:C:A | Distant upstream | 0.0272066930013826 | 0.0421460612673169 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs56189543 | chr7:100718426:G:C | Distant upstream | 0.0269570947012015 | 0.0443136595360931 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs475339 | chr7:100718744:T:G | Distant upstream | 0.0269570947012015 | 0.0443136595360931 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs2432930 | chr7:100701401:A:G | Distant upstream | 0.0271337803110642 | 0.0461756216865796 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs221772 | chr7:100703275:T:C | Distant upstream | 0.0271337803110642 | 0.0461756216865796 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs221771 | chr7:100704202:G:A | Distant upstream | 0.0271337803110642 | 0.0461756216865796 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs221799 | chr7:100690922:G:A | Distant upstream | 0.0272862916773879 | 0.0476749505554464 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs221801 | chr7:100692408:C:A | Distant upstream | 0.0272862916773879 | 0.0476749505554464 | KIRC | Male-baised sQTL |
| exon_skip_469348 | chr7:100856867:100857176 | In-frame | rs507392 | chr7:100722313:G:A | Distant upstream | 0.0268744965227711 | 0.0491169316054175 | KIRC | Male-baised sQTL |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
 | EX ID: exon_skip_469348 |
| CpG Site: cg04305808 | |
| Position to EX: Distant upstream | |
| Male Effect: - | |
| Female Effect: 0.0566000401002506 |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_469348 | chr7:100856867:100857176 | cg04305808 | chr7:100016586 | Distant upstream | 0.0566000401002506 | 3.09872467404662e-05 | 0.4497829392628796 | 5.155995922557352e-07 | In-frame | SARC |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of SLC12A9 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
